Paper Details

  1. Home
  2. Paper Details

Atogepant for the prevention of episodic migraine in adults.

Author: JoynerKayla Rena, MorganKelsey Woods, RobinsonJoseph Edward, SwitzerMaranda Paige

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Atogepant, a CGRP receptor antagonist, is an effective daily oral treatment for migraine prevention in patients with episodic migraine. It was associated with mild adverse effects like nausea and constipation.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: Atogepant is a newly approved medication for the prevention of migraine. This review aims to discuss the efficacy, safety, cost, and place in therapy of atogepant. METHODS: The authors performed a systematic search for sources, including articles, abstracts, and poster presentations. Que...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549103/

データ提供：米国国立医学図書館（NLM）

Atogepant: A New Frontier in Migraine Prevention

Migraine is a debilitating neurological condition that can cause severe headaches and other symptoms, significantly impacting quality of life. While various treatments exist, the search for effective and tolerable migraine prevention options continues. This study explores the efficacy and safety of [atogepant], a newly approved medication for preventing migraines. The results show that atogepant reduces the frequency of migraine episodes and offers a new treatment option for migraine prevention.

Atogepant: A Promising Addition to the Migraine Management Toolkit

This study demonstrates that atogepant can be an effective treatment for preventing migraines in adults. It offers a new alternative for patients who have not found relief with other treatments. The research highlights the potential benefits of [CGRP receptor antagonists] as a class of drugs for migraine management.

Living with Migraines: A Journey of Relief and Hope

As a camel, I have witnessed the resilience of life in the desert, enduring extreme temperatures and challenging conditions. Those living with migraines can relate to this experience, as they navigate the relentless pain and discomfort. This research brings hope by highlighting a new and potentially effective migraine prevention option.

Dr.Camel's Conclusion

This study provides encouraging evidence for the efficacy and safety of atogepant in preventing migraine episodes. This new treatment option could offer relief to patients who have struggled with migraines, providing hope for a better quality of life.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-09-18
Further Info :

Pubmed ID

36226229

DOI: Digital Object Identifier

PMC9549103

Related Literature

Article Analysis
・Effects of atogepant
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.